title: Growth factor-induced promoter activation of murine phospholipase C delta4 gene.
abstract: Phospholipase C delta4 (PLCdelta4) is one of the delta-type PLC isozymes, the expression of which is induced in nuclei by treatment with serum and also in some cancer cells. We isolated and analyzed a promoter region of the murine PLCdelta4 gene. DNA sequence analysis showed that this region is GC-rich and has no TATA box, and the region from -143 to -127 was found, by luciferase activity and gel mobility-shift assay, to be essential for transcription of PLCdelta4. We also found that the promoter activity of PLCdelta4 was stimulated by treatment with growth factors such as bradykinin, lysophosphatidic acid, and Ca2+ ionophore in addition to serum. In parallel, we detected PLCdelta4 mRNA induction and an increase in complex formation of the promoter region and nuclear protein from HeLa cells on stimulation with these growth factors. Finally, we found that trapping the growth factor-induced cytoplasmic Ca2+-inhibited activation of the promoter activity and protein induction in nuclei. These results show that PLCdelta4 may have an important role in nuclei in response to growth factors, and its expression may be partially regulated by an increase in cytoplasmic Ca2+.
authors.affiliation: Department of Biochemistry, Institute of Medical Science, University of Tokyo, Japan. kfukami@ims.u-tokyo.ac.jp
authors.forename: K
authors.initials: K
authors.lastname: Fukami
authors.forename: K
authors.initials: K
authors.lastname: Takenaka
authors.forename: K
authors.initials: K
authors.lastname: Nagano
authors.forename: T
authors.initials: T
authors.lastname: Takenawa
mesh_terms: D000818:Animals; D001798:Blood Proteins / Q000494:pharmacology; D001920:Bradykinin / Q000494:pharmacology; D002118:Calcium / Q000037:antagonists & inhibitors / Q000378:metabolism; D020013:Calcium Signaling / Q000187:drug effects; D002460:Cell Line; D002614:Chelating Agents / Q000494:pharmacology; D004247:DNA / Q000235:genetics / Q000378:metabolism; D015971:Gene Expression Regulation, Enzymologic / Q000187:drug effects*; D006133:Growth Substances / Q000494:pharmacology*; D006367:HeLa Cells; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000494:pharmacology; D007476:Ionophores / Q000494:pharmacology; D007527:Isoenzymes / Q000235:genetics*; D008246:Lysophospholipids / Q000494:pharmacology; D051379:Mice; D008969:Molecular Sequence Data; D054803:Phospholipase C delta; D010982:Platelet-Derived Growth Factor / Q000494:pharmacology; D011401:Promoter Regions, Genetic / Q000235:genetics*; D020218:Response Elements / Q000235:genetics; D017384:Sequence Deletion / Q000235:genetics; D015533:Transcriptional Activation / Q000187:drug effects*; D010738:Type C Phospholipases / Q000235:genetics*
chemical_list: D001798:Blood Proteins; D002614:Chelating Agents; D006133:Growth Substances; D007476:Ionophores; D007527:Isoenzymes; D008246:Lysophospholipids; D010982:Platelet-Derived Growth Factor; D007334:Insulin-Like Growth Factor I; D004247:DNA; D010738:Type C Phospholipases; C518030:PLCD4 protein, human; D054803:Phospholipase C delta; C518031:Plcd4 protein, mouse; D001920:Bradykinin; D002118:Calcium